Recombinant peptides with high avidity for binding with particular protein targets for the purpose of treating mammalian diseases, namely, inflammatory, immunological, rheumatological, neurological, oncological, hematological, urological, nephrological, metabolic, endocrinological, pulmonary, cardiovascular, musculoskeletal, infectious, ophthalmological, otolaryngological, neoplastic, autoimmune and renal diseases, for use in the treatment of loss of bone mass, chronic anemia, hyperparathyroidism, hypercalcemia, bone metabolism related diseases and disorders, human immune diseases and conditions, viral infections, injury to epithelial cells and tissues, obesity, diabetes, hypertension, dyslipidemia, infertility, surgical or soft tissue damage and injury to epithelial cells and tissues, for use in stimulating production of red blood cells, white blood cells, platelets and platelet precursor cells, for modulating calcium, phosphorous, or parathyroid hormone levels in the blood, and for use in anticancer and antiviral applications, modulating weight loss, regulating reproductive function, promoting wound healing, preventing the loss of bone mass, restoring the level of white blood cells, promoting growth and differentiation of neurons and preventing neuronal death
Pharmaceuticals